What an incredible day 3 at #EuroPCR2022 where our EMJ team attended a case-based discussion on updated techniques… twitter.com/i/web/status/1…
Posted 19 May
This morning at #EuroPCR2022 we are looking forward to the session on the future of TAVI. #interventionalcardiology #TAVI
Posted 19 May
On Day 2 of #EuroPCR2022 we are excited to hear about the late breaking trials on #TAVI
Posted 18 May
It’s fascinating to attend a session on image-guided bifurcation stenting in vitro beating heart simulation live fr… twitter.com/i/web/status/1…
Posted 18 May
What an amazing first day it has been at #EuroPCR2022. Our team attended a great session on AI in #interventional… twitter.com/i/web/status/1…
Posted 17 May
Latest abstracts
All abstracts
The Incidence and Short-Term Outcomes of Periprocedural Myocardial Infarction Following Cardiac Surgery Across Two International Definitions Using the High-Sensitivity Troponin Assay
There are currently two guideline-recommended diagnostic criteria in use to define a periprocedural myocardial infarction (PPMI) following coronary artery bypass grafting (CABG): the 4th Universal Definition of Myocardial Infarction (UDMI) and the Society of Cardiovascular Angiography and Interventions (SCAI).
Read More

Diagnostic Performance of Quantitative Flow Ratio Compared to Fractional Flow Reserve and Instantaneous Wave-Free Ratio for Physiology Evaluation of Intermediate Coronary Artery Stenosis
European and American experts recommend physiology-guided myocardial revascularisation.1,2,3 Nevertheless, physiology-guided revascularisation does not exceed 10% in the best scenario, worldwide.
Read More

Feasibility of Slender CTO PCI Transradially with Limited Use of Hardware
Treating chronic total occlusions (CTO) by the antegrade approach requires appropriate devices and skill in resource-limited settings. Good guide-catheter support is crucial.1,2 Patients with diabetes and narrower radial arteries are prone to spasm with larger guiding catheters, and may benefit from a slender approach to percutaneous coronary intervention (PCI).
Read More

Full Bioresorbable Jacket with Magmaris™ Magnesium Scaffold: A Case Series
Bioresorbable vascular scaffolds (BRS) are a new and promising technology. BRS have been developed to provide the same advantages as drug-eluting stents, including radial strength, prevention of vessel recoil, and release of an antiproliferative drug.
Read More